ATS and IDSA Release New Guidelines for Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia

The American Thoracic Society (ATS) and the Infectious Disease Society of America (IDSA) have released new guidelines for the management of adults with hospital-acquired and ventilator-associated pneumonia. Major updates include a recommendation to shorten antibiotic therapy to 7 days (from 8 to 15) and consider discontinuation of antibiotic therapy based on procalcitonin levels and clinical criteria. In diagnosed cases of HAP and VAP, Avisa believes that once approved, its 13C-Urea BreathTest will aid antibiotic choice and similar to procalcitonin, will provide quantitative measures of antibiotic efficacy to aid decisions on antibiotic de-escalation. The 2016 guidelines replace the last update done in 2005.